The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis.
Six siblings were screened for clinical and biochemical evidence of tumoral calcinosis. The 3 brothers showed all the characteristic manifestations of this entity. Two of them were treated for an initial period of 6 months with large doses of thyrocalcitonin, with virtually no response. After a 9-month equilibration period they were treated by phosphate depletion, and at the end of 6 months they were re-investigated. There was no appreciable objective or radiological difference in the extent of the masses. It was concluded that, in these 2 patients, surgical excision of the tumours was the only feasible form of therapy.
D000328:Adult; D002114:Calcinosis / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D002116:Calcitonin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010710:Phosphates / Q000494:pharmacology*
D010710:Phosphates; D002116:Calcitonin